These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37690146)

  • 21. Generation by reverse genetics of an effective, stable, live-attenuated newcastle disease virus vaccine based on a currently circulating, highly virulent Indonesian strain.
    Xiao S; Nayak B; Samuel A; Paldurai A; Kanabagattebasavarajappa M; Prajitno TY; Bharoto EE; Collins PL; Samal SK
    PLoS One; 2012; 7(12):e52751. PubMed ID: 23285174
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemagglutinin-neuraminidase gene of genotype VII Newcastle disease virus strains isolated in Japan.
    Mase M
    J Vet Med Sci; 2022 Jan; 84(1):1-5. PubMed ID: 34789612
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generation of a recombinant chimeric Newcastle disease virus vaccine that allows serological differentiation between vaccinated and infected animals.
    Peeters BP; de Leeuw OS; Verstegen I; Koch G; Gielkens AL
    Vaccine; 2001 Feb; 19(13-14):1616-27. PubMed ID: 11166884
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genotype-matched Newcastle disease virus vaccine confers improved protection against genotype XII challenge: The importance of cytoplasmic tails in viral replication and vaccine design.
    Izquierdo-Lara R; Chumbe A; Calderón K; Fernández-Díaz M; Vakharia VN
    PLoS One; 2019; 14(11):e0209539. PubMed ID: 31725727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biological Significance of Dual Mutations A494D and E495K of the Genotype III Newcastle Disease Virus Hemagglutinin-Neuraminidase In Vitro and In Vivo.
    Lu X; Zhan T; Liu K; Chen Y; Hu Z; Hu J; Gu M; Hu S; Wang X; Liu X; Liu X
    Viruses; 2022 Oct; 14(11):. PubMed ID: 36366435
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A vaccine candidate of attenuated genotype VII Newcastle disease virus generated by reverse genetics.
    Hu S; Ma H; Wu Y; Liu W; Wang X; Liu Y; Liu X
    Vaccine; 2009 Feb; 27(6):904-10. PubMed ID: 19095026
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Newcastle disease virus fusion protein is the major contributor to protective immunity of genotype-matched vaccine.
    Kim SH; Wanasen N; Paldurai A; Xiao S; Collins PL; Samal SK
    PLoS One; 2013; 8(8):e74022. PubMed ID: 24015313
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of fusion protein cleavage site sequence on generation of a genotype VII Newcastle disease virus vaccine.
    Manoharan VK; Varghese BP; Paldurai A; Samal SK
    PLoS One; 2018; 13(5):e0197253. PubMed ID: 29758054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccination against Newcastle disease with a recombinant baculovirus hemagglutinin-neuraminidase subunit vaccine.
    Nagy E; Krell PJ; Dulac GC; Derbyshire JB
    Avian Dis; 1991; 35(3):585-90. PubMed ID: 1953580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Saume E
    Avian Dis; 2008 Jun; 52(2):253-9. PubMed ID: 18646454
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved protection from velogenic Newcastle disease virus challenge following multiple immunizations with plasmid DNA encoding for F and HN genes.
    Loke CF; Omar AR; Raha AR; Yusoff K
    Vet Immunol Immunopathol; 2005 Jul; 106(3-4):259-67. PubMed ID: 15963824
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Positive selection in the hemagglutinin-neuraminidase gene of Newcastle disease virus and its effect on vaccine efficacy.
    Gu M; Liu W; Xu L; Cao Y; Yao C; Hu S; Liu X
    Virol J; 2011 Mar; 8():150. PubMed ID: 21453506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel recombinant attenuated Newcastle disease virus expressing H9 subtype hemagglutinin protected chickens from challenge by genotype VII virulent Newcastle disease virus and H9N2 avian influenza virus.
    Xu X; Xue C; Liu X; Li J; Fei Y; Liu Z; Mu J; Bi Y; Qian J; Yin R; Ding Z
    Vet Microbiol; 2019 Jan; 228():173-180. PubMed ID: 30593364
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of genomic and antigenic properties of Newcastle Disease virus genotypes II, XXI and VII from Egypt do not point to antigenic drift as selection marker.
    Naguib MM; Höper D; Elkady MF; Afifi MA; Erfan A; Abozeid HH; Hasan WM; Arafa AS; Shahein M; Beer M; Harder TC; Grund C
    Transbound Emerg Dis; 2022 Mar; 69(2):849-863. PubMed ID: 33955204
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of phylogenetic diversity of velogenic Newcastle disease virus challenge on virus shedding post homologous and heterologous DNA vaccination in chickens.
    Mohamed MH; Abdelaziz AM; Kumar S; Al-Habib MA; Megahed MM
    Avian Pathol; 2016; 45(2):228-34. PubMed ID: 26813237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Newcastle disease LaSota vaccine-induced hemagglutination inhibition antibodies against challenges with heterologous virulent strains of genotypes VII and IX.
    Liu M; Shen X; Li J; Yu Y; Fan J; Jia X; Dai Y
    Vet Immunol Immunopathol; 2023 May; 259():110591. PubMed ID: 37030151
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Construction of Novel Thermostable Chimeric Vaccine Candidates for Genotype VII Newcastle Disease Virus.
    Cao Y; Bo Z; Ruan B; Guo M; Zhang C; Zhang X; Wu Y
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a genotype VII Newcastle disease virus vaccine candidate with high yield in embryonated chicken eggs.
    Hu Z; Hu S; Meng C; Wang X; Zhu J; Liu X
    Avian Dis; 2011 Sep; 55(3):391-7. PubMed ID: 22017036
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hemagglutinin-neuraminidase Sequence and Phylogenetic Analysis of Two Newcastle Disease Virus Isolated from Chickens in Iran.
    Kiani MH; Bozorgmehrifard MH; Hosseini H; Charkhkar S; Ghalyanchilangeroudi A
    Arch Razi Inst; 2021 Mar; 76(1):31-39. PubMed ID: 33818955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A genotype VII Newcastle disease virus-like particles confer full protection with reduced virus load and decreased virus shedding.
    Xu X; Ding Z; Yuan Q; Ding J; Li J; Wang W; Cong Y; Ouyang W; Wang Y; Qian J; Yin R
    Vaccine; 2019 Jan; 37(3):444-451. PubMed ID: 30545716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.